BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10190298)

  • 1. Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans.
    Kawai K; Takahashi H; Watarai S; Ishizu H; Fukai K; Tanabe Y; Nose S; Kuroda S
    Virchows Arch; 1999 Mar; 434(3):201-5. PubMed ID: 10190298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of GD3 ganglioside in reactive astrocytes--an immunocytochemical study in the rat brain.
    Kawai K; Kuroda S; Watarai S; Takahashi H; Ikuta F
    Neurosci Lett; 1994 Jun; 174(2):225-7. PubMed ID: 7970185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside content and composition in human gliomas.
    Gaini SM; Riboni L; Cerri C; Grimoldi N; Sganzerla EP; Berra B
    Acta Neurochir Suppl (Wien); 1988; 43():126-9. PubMed ID: 2850730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
    Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
    Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
    Fabris D; Rožman M; Sajko T; Vukelić Ž
    Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of P-glycoprotein as a multidrug resistance gene product in human reactive astrocytes and astrocytoma].
    Dietzmann K; Bossanyi PV; Franke DS
    Zentralbl Pathol; 1994 Jul; 140(2):149-53. PubMed ID: 7947620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
    Mennel HD; Lell B
    Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.
    Birks SM; Danquah JO; King L; Vlasak R; Gorecki DC; Pilkington GJ
    Neuro Oncol; 2011 Sep; 13(9):950-60. PubMed ID: 21807667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.
    Sung CC; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
    Cancer; 1994 Dec; 74(11):3010-22. PubMed ID: 7954264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of ganglioside GD3 in the central nervous system.
    Kawai K; Mori M; Watarai S; Yasuda T
    Neurosci Res; 1994 Mar; 19(2):119-24. PubMed ID: 8008240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside GD3 shedding by human gliomas.
    Nakamura O; Iwamori M; Matsutani M; Takakura K
    Acta Neurochir (Wien); 1991; 109(1-2):34-6. PubMed ID: 1648861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading.
    Wagener R; Röhn G; Schillinger G; Schröder R; Kobbe B; Ernestus RI
    Acta Neurochir (Wien); 1999; 141(12):1339-45. PubMed ID: 10672306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study.
    Nabeshima K; Shimao Y; Sato S; Kataoka H; Moriyama T; Kawano H; Wakisaka S; Koono M
    Histopathology; 1997 Nov; 31(5):436-43. PubMed ID: 9416484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
    von Holst H; Nygren C; Boström K; Collins VP; Fredman P
    Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
    Kristt DA; Reedy E; Yarden Y
    Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia.
    Gratsa A; Rooprai HK; Rogers JP; Martin KK; Pilkington GJ
    Anticancer Res; 1997; 17(6B):4111-7. PubMed ID: 9428343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme.
    Hoshino T; Townsend JJ; Muraoka I; Wilson CB
    Brain; 1980 Dec; 103(4):967-84. PubMed ID: 6254610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of ganglioside GD3 in human reactive astrocytes.
    Kawai K; Watarai S; Takahashi H; Ishizu H; Fukai K; Tanabe Y; Yokota O; Kuroda S
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):79-82. PubMed ID: 10201289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmunology of gangliosides in human neurons and glial cells in culture.
    Kim SU; Moretto G; Lee V; Yu RK
    J Neurosci Res; 1986; 15(3):303-21. PubMed ID: 3701884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
    Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.